| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.08 |